Carbetimer: a re-evaluation of a drug with a novel mechanism of action.
Ardalan
B
B
Department of Oncology, Sylvester Comprehensive Cancer Center, University of Miami Medical School, Jackson Memorial Hospital, Florida.
Hussein
A M
AM
Shanahan
W R
WR
Shields
M J
MJ
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004341:Drug Evaluation; D006801:Humans; D011108:Polymers / Q000494:pharmacology*
D000970:Antineoplastic Agents; D011108:Polymers; C022084:carboxyimamidate